The U.S. Food and Drug Administration (FDA) announced it is initiating the removal of ‘black box’ warning labels from hormone replacement therapy (HRT) products used to ease menopause symptoms, a move Commissioner Dr. Marty Makary…
-
-
Speaker Mike Johnson, R-La., is anticipating the House could vote to end the government shutdown as early as Wednesday, Fox News Digital is told. The House GOP leader held a lawmaker-only call late on Monday…
-
Lawyers for roughly two dozen states will head to court Monday to block the Trump administration’s attempt to penalize them for making full payments to Supplemental Nutrition Assistance Program (SNAP) recipients. The filing is the…
-
The shutdown stalemate that has dragged on in the Senate officially ended late Monday night, and it places Congress on a path to reopen the government later this week. Senators advanced a bipartisan funding package…
-
As COP30 convenes in Belém, Brazil, the global urgency to tackle climate change feels sharper than ever. Meeting ambitious sustainability goals requires mobilizing vast amounts of capital toward clean energy and climate solutions, an endeavor…
-
(TheNewswire) TORONTO TheNewswire – November 10, 2025 Noble Mineral Exploration Inc. (‘ Noble ‘ or the ‘ Company ‘) (TSXV: NOB,OTC:NLPXF) (OTCQB: NLPXF) is pleased to announce that it is undertaking a non-brokered private placement…
-
Corazon Mining (CZN:AU) has announced Two Pools Gold Project update Download the PDF here. This post appeared first on investingnews.com
-
As humanity edges closer to mining the moon, industry analysts warn that established mining companies, not venture-backed space startups, may dominate the emerging lunar resource sector. The space mining market, projected to reach US$20 billion…
-
Sound money advocate and author Larry Lepard shares his thoughts on what’s driving gold, silver and Bitcoin prices, as well as how high they could rise in the near term. ‘I sincerely believe that in…
-
Investing
InMed Pharmaceuticals: Innovating Cannabinoid-inspired Medicines, Backed by Real Revenue and Clear Path to Value
InMed Pharmaceuticals (NASDAQ: INM) pairs innovative therapeutic development in Alzheimer’s, ophthalmology, and dermatology with recurring revenue from its BayMedica manufacturing division — giving investors rare small-cap biotech exposure to high-impact science with reduced financing risk.…